The association for U.S. for-profit hospitals submitted a brief to the U.S. Supreme Court and released a study today arguing against reversing the nearly 30 percent cut in what Medicare pays many public and private nonprofit hospitals for physician-administered, 340B-purchased drugs.
The Federation of American Hospitals’ (FAH) legal brief and study are likely a disappointment for fellow hospital associations trying to get the cuts reversed for their 340B hospitals members. Three of those groups—the American Hospital Association (AHA), the Association of American Medical Colleges (AAMC), and America’s Essential Hospitals—asked the Supreme Court in February to overturn a federal appeals court’s 2-1 decision in July 2020 upholding the reimbursement reductions, which began in 2018 and total an estimated $1.6 billion annually.
The association for U.S. for-profit hospitals submitted a brief to the U.S. Supreme Court and released a study today arguing against reversing the nearly 30 percent cut in what Medicare pays many public and private nonprofit hospitals for physician-administered, 340B-purchased drugs.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
